Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study

J. Dollerup, C. Suppli Ulrik, T. Brunse HØjmark, K. Rose Olsen, P. Vedsted (Broendby, Hvidovre, Aarhus, Denmark)

Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Session: Quality of life and respiratory symptoms in primary care COPD populations
Session type: Thematic Poster Session
Number: 2380
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Dollerup, C. Suppli Ulrik, T. Brunse HØjmark, K. Rose Olsen, P. Vedsted (Broendby, Hvidovre, Aarhus, Denmark). Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study. Eur Respir J 2013; 42: Suppl. 57, 2380

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
One year with certified asthma and COPD-clinics in Skåne, Sweden
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Validation of the COPD control concept: A UK pilot
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


The economic burden of COPD in a Swedish cohort: The ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Inappropriate prescriptions following initial COPD diagnosis
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


The association between COPD treatment adherence and patient outcomes in Europe and the US
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016


REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Medication prescribing for COPD in primary care databases
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


ICS and risk of pneumonia in Swedish COPD patients: The ARCTIC study
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016

The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013